WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

India may extend duty exemptions on pharma inputs beyond June 30

India is reviewing the months-old duty-related relief measures for pharma sector amid the evolving situation in West Asia and likely to extend the exemptions beyond June 30, a senior official in the Centre’s Department of Commerce said here on Tuesday.

Raccontata daeconomictimes.indiatimes.comthehindu.comtheprint.in

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
thehindu.comStai leggendo2 g fa

India may extend duty exemptions on pharma inputs beyond June 30

India is reviewing the months-old duty-related relief measures for pharma sector amid the evolving situation in West Asia and likely to extend the exemptions beyond June 30, a senior official in the Centre’s Department…

originale
economictimes.indiatimes.com2 g fa

India considers extending import tax exemption on petrochemicals to beyond June 30

India will ​consider extending import tax exemptions on ‌petrochemicals ⁠used ⁠for ​making plastics and ​pharmaceutical goods beyond June 30 ​to ⁠help local ‌industries, ​Ravi ​Teja, ⁠deputy director at ​the Department…

Leggi questa versione → originale
theprint.in20 h fa

India moves to diversify pharma exports & cut US market dependence, eyes $130 billion target by 2030

India targets $130B pharma exports by 2030 through Southeast Asia hubs and market diversification, reducing US dependency from 33%. The supply-chain pivot signals healthcare sovereignty; watch regulatory harmonization, vendor risks, and SaaS logistics opportunities in new pharma hubs.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 9 giugno 2026·economictimes.indiatimes.com

    India considers extending import tax exemption on petrochemicals to beyond June 30

    India will ​consider extending import tax exemptions on ‌petrochemicals ⁠used ⁠for ​making plastics and ​pharmaceutical goods beyond June 30 ​to ⁠help local ‌industries, ​Ravi…

  2. martedì 9 giugno 2026·thehindu.com

    India may extend duty exemptions on pharma inputs beyond June 30

    India is reviewing the months-old duty-related relief measures for pharma sector amid the evolving situation in West Asia and likely to extend the exemptions beyond June 30, a…

  3. martedì 9 giugno 2026·economictimes.indiatimes.com

    Duty relief may be extended for petrochemical inputs for pharma

    Ravi Teja, deputy director at the Department of Commerce, told reporters in Hyderabad on Tuesday that a review is underway for a possible extension, but did not reveal the new…

  4. giovedì 11 giugno 2026·theprint.in

    India moves to diversify pharma exports & cut US market dependence, eyes $130 billion target by 2030

    Commerce ministry kicks off measures to insulate drug makers in wake of West Asia crisis. Renewed focus on Europe, Latin America, Africa among steps to grow ‘pharmacy of the…